These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 18270297)

  • 1. Stability of gadolinium chelates and their biological consequences: new data and some comments.
    Port M; Idee JM; Medina C; Dencausse A; Corot C
    Br J Radiol; 2008 Mar; 81(963):258-9. PubMed ID: 18270297
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nephrotoxicity of contrast media in magnetic resonance tomography (MRI)].
    Heuck A; Reiser M
    Internist (Berl); 1997 Dec; 38(12):1234-5. PubMed ID: 9465330
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution and chemical forms of gadolinium in the brain: a review.
    Kanda T; Nakai Y; Hagiwara A; Oba H; Toyoda K; Furui S
    Br J Radiol; 2017 Nov; 90(1079):20170115. PubMed ID: 28749164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical properties of gadoteridol and other magnetic resonance contrast agents.
    Tweedle MF
    Invest Radiol; 1992 Aug; 27 Suppl 1():S2-6. PubMed ID: 1506149
    [No Abstract]   [Full Text] [Related]  

  • 5. Organ retention of gadolinium in mother and pup mice: effect of pregnancy and type of gadolinium-based contrast agents.
    Erdene K; Nakajima T; Kameo S; Khairinisa MA; Lamid-Ochir O; Tumenjargal A; Koibuchi N; Koyama H; Tsushima Y
    Jpn J Radiol; 2017 Oct; 35(10):568-573. PubMed ID: 28730467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of gadolinium chelates in mice: relationship to chemical characteristics.
    Wedeking P; Kumar K; Tweedle MF
    Magn Reson Imaging; 1992; 10(4):641-8. PubMed ID: 1501535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal handling and physiologic effects of the paramagnetic contrast medium, gadolinium-DOTA.
    Katzberg RW; Sahler LG; Duda SW; Morris TW; McKenna BA; Pabico RC; Niedrach WL; Tonetti FW
    Invest Radiol; 1991 Nov; 26 Suppl 1():S129-30; discussion S137-8. PubMed ID: 1808108
    [No Abstract]   [Full Text] [Related]  

  • 8. Subcellular localisation of gadolinium in the rat brain.
    Allard M; Kien P; Caille JM; Bonnemain B; Doucet D; Simonnet G
    J Neuroradiol; 1987; 14(2):159-62. PubMed ID: 3681416
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and evaluation of macrocyclic gadolinium chelates as hepatospecific MRI agents.
    Marinelli ER; Neubeck R; Song B; Wagler T; Ranganathan RS; Sukumaran K; Wedeking P; Nunn A; Runge V; Tweedle M
    Acad Radiol; 2002 May; 9 Suppl 1():S251-4. PubMed ID: 12019882
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain distribution of MRI contrast media in rats after intracisternal injection.
    Allard M; Kien P; Caille JM; Bonnemain B; Simonnet G
    J Neuroradiol; 1987; 14(4):383-7. PubMed ID: 3131496
    [No Abstract]   [Full Text] [Related]  

  • 11. Distribution profile of gadolinium in gadolinium chelate-treated renally-impaired rats: role of pharmaceutical formulation.
    Fretellier N; Salhi M; Schroeder J; Siegmund H; Chevalier T; Bruneval P; Jestin-Mayer G; Delaloge F; Factor C; Mayer JF; Fabicki JM; Robic C; Bonnemain B; Idée JM; Corot C
    Eur J Pharm Sci; 2015 May; 72():46-56. PubMed ID: 25736527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of magnetic resonance imaging contrast agents.
    Shellock FG; Kanal E
    J Magn Reson Imaging; 1999 Sep; 10(3):477-84. PubMed ID: 10508312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gd-DOTA: characterization of a new paramagnetic complex.
    Bousquet JC; Saini S; Stark DD; Hahn PF; Nigam M; Wittenberg J; Ferrucci JT
    Radiology; 1988 Mar; 166(3):693-8. PubMed ID: 3340763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid relaxation times measurements by MRI: an in vivo application to contrast agent modeling for muscle fiber types characterization.
    Dedieu V; Fau P; Otal P; Renou JP; Emerit V; Joffre F; Vincensini D
    Magn Reson Imaging; 2000 Dec; 18(10):1221-33. PubMed ID: 11167042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of excess gadolinium into human bone from medical contrast agents.
    Darrah TH; Prutsman-Pfeiffer JJ; Poreda RJ; Ellen Campbell M; Hauschka PV; Hannigan RE
    Metallomics; 2009 Nov; 1(6):479-88. PubMed ID: 21305156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P760: a new gadolinium complex characterized by a low rate of interstitial diffusion.
    Port M; Corot C; Raynal I; Dencausse A; Schaefer M; Rousseaux O; Simonot C; Devoldere L; Lin J; Foulon M; Bourrinet P; Bonnemain B; Meyer D
    Acad Radiol; 2002 May; 9 Suppl 1():S17-9. PubMed ID: 12019859
    [No Abstract]   [Full Text] [Related]  

  • 17. Dynamic magnetic resonance imaging of head and neck lesions.
    Baba Y; Yamashita Y; Onomichi M; Murakami R; Takahashi M
    Top Magn Reson Imaging; 1999 Apr; 10(2):125-9. PubMed ID: 10551627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual or retained gadolinium: practical implications for radiologists and our patients.
    Kanal E; Tweedle MF
    Radiology; 2015 Jun; 275(3):630-4. PubMed ID: 25942418
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in macrocyclic gadolinium complexes as magnetic resonance imaging contrast agents.
    Meyer D; Schaefer M; Doucet D
    Invest Radiol; 1990 Sep; 25 Suppl 1():S53-5. PubMed ID: 2132570
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy.
    White GW; Gibby WA; Tweedle MF
    Invest Radiol; 2006 Mar; 41(3):272-8. PubMed ID: 16481910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.